We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
(+61%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
34.3%
Top 10 Holdings %
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
+$645M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$539M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$525M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$520M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$475M |
| 2 |
RP
RealPage, Inc.
RP
|
+$281M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$209M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$170M |
| 5 |
CLGX
Corelogic, Inc.
CLGX
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.31% |
| 2 | Healthcare | 16.38% |
| 3 | Financials | 13.99% |
| 4 | Communication Services | 7.66% |
| 5 | Consumer Discretionary | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Bolt Biotherapeutics
BOLT
$7.71M
| – | – |
-950
| Closed | -$625K |
|
852
Bentley Systems
BSY
$10.7B
| – | – |
-235,000
| Closed | -$11M |
|
853
Boston Properties
BXP
$11.1B
| – | – |
-20,515
| Closed | -$2.08M |
|
854
Carrier Global
CARR
$53.2B
| – | – |
-265,455
| Closed | -$11.2M |
|
855
Cameco
CCJ
$42.3B
| – | – |
-225,000
| Closed | -$3.74M |
|
856
PUT
Carnival Corporation Ltd
CCL
$39.2B
| – | – |
-100,000
| Closed | -$132K |
|
|
CELUW
857
DELISTED
Celularity Inc
CELUW
| – | – |
-120,753
| Closed | -$132K |
|
858
ChargePoint
CHPT
$160M
| – | – |
-2,500
| Closed | -$1.33M |
|
859
Cigna
CI
$74.2B
| – | – |
-50,000
| Closed | -$12.1M |
|
860
CME Group
CME
$95.6B
| – | – |
-15,000
| Closed | -$3.06M |
|
|
GPGI
861
GPGI Inc
GPGI
$4.29B
| – | – |
-180,594
| Closed | -$1.49M |
|
862
Canadian National Railway
CNI
$77.2B
| – | – |
-157,457
| Closed | -$18.3M |
|
863
CrowdStrike
CRWD
$216B
| – | – |
-33,600
| Closed | -$1.53M |
|
864
CALL
Dominion Energy
D
$59.5B
| – | – |
-200,000
| Closed | -$1.21M |
|
865
Devon Energy
DVN
$47.9B
| – | – |
-261,761
| Closed | -$5.72M |
|
|
EA
866
DELISTED
Electronic Arts
EA
| – | – |
-28,000
| Closed | -$3.79M |
|
867
Equinix
EQIX
$104B
| – | – |
-7,065
| Closed | -$4.8M |
|
868
Entergy
ETR
$50.5B
| – | – |
-54,422
| Closed | -$2.71M |
|
869
EVgo
EVGO
$216M
| – | – |
-300,000
| Closed | -$4.11M |
|
|
FISV
870
Fiserv Inc
FISV
$27.6B
| – | – |
-165,000
| Closed | -$19.6M |
|
871
GoodRx Holdings
GDRX
$1.26B
| – | – |
-190,000
| Closed | -$7.41M |
|
872
Generac Holdings
GNRC
$12.7B
| – | – |
-7,191
| Closed | -$2.35M |
|
873
W.W. Grainger
GWW
$60.3B
| – | – |
-20,000
| Closed | -$8.02M |
|
874
iShares Global Clean Energy ETF
ICLN
$2.4B
| – | – |
-40,000
| Closed | -$972K |
|
875
InnovAge Holding
INNV
$1.49B
| – | – |
-15,000
| Closed | -$387K |
|
Similar funds
FNBT
SAG
ACI
RC
A
CGL
CB
JCM
UBS O'Connor's Q2 2021 Portfolio in Review
As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.
- UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
- UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
- UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
- UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
- UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
- UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
- UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.
Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.